Question

what will happen if not everyone can be vaccinated by sinovac?​

Answer 1

Explanation:

It has an efficacy rate of 50.4% for preventing symptomatic infection, according to data from a Brazilian trial, and an effectiveness of 67%, according to a real-world study in Chile. Sinovac's vaccine was validated for Emergency Use Listing (EUL) by the WHO on June 1.

✪============♡============✿

$\huge \pink{✿} \red {M} \green {i} \blue {s} \orange {s} \pink {/} \red {B} \blue {h} \pink {u} \red {t} \green {n} \orange {i} \pink {♡}$